SECTION 32, LLC

SECTION 32, LLC is a Pre-seed, Seed, Series A, Series B, Series C+, buyout, secondary, debt and other fund in the US, Europe and Asia investing in AI, Enterprise, Fintech, Healthcare, Security, technology, quantum-computing, computational-biology and biotechnology.

Stages: Pre-seed, Seed, Series A, Series B, Series C+, buyout, secondary, debt, other
Sectors: AI, Enterprise, Fintech, Healthcare, Security, technology, quantum-computing, computational-biology, biotechnology
Invests in: US-wide, Europe, Asia
Actively investing: Yes
Founded: 2017
Assets under management: $2B
Website: s32.com

Check size not disclosed

Thesis

The firm focuses on technology and healthcare, including artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology. It invests across all stages, with a focus on early-stage companies in the United States, Europe, and Asia. Section 32 aims to invest in disruptive and impactful founders, focusing on long-term partnerships and providing strategic guidance and operational support. The firm manages over $2 billion in AUM, with multiple funds raised, including a Fund 6 targeting $600 million.

Common questions

Does SECTION 32, LLC invest at the Pre-seed stage?

Yes. SECTION 32, LLC lists Pre-seed, Seed, Series A, Series B, Series C+, buyout, secondary, debt and other among the stages it invests in.

Where does SECTION 32, LLC invest?

SECTION 32, LLC invests in the US, Europe and Asia.